Inflammatory Myofibroblastic Tumor Of Urinary Bladder

  • Ronica Baruah Ekopath Metropolis Lab Services Pvt. Ltd. Christian Basti, G.S.Road, Guwahati, Assam.
  • Abhijit Kalita Ekopath Metropolis Lab Services Pvt. Ltd. Christian Basti, G.S.Road, Guwahati, Assam.
  • Phanindra Mohan Deka Department of Urology, Dispur Hospitals Pvt. Ltd., Guwahati
Keywords: ALK 1 immunostain, Inflammatory myofibroblastic tumor, spindle myoepithelial cell proliferation.

Abstract

Inflammatory  myofibroblastic  tumor  (IMT)  is  an  uncommon  benign  tumor  of  intermediate  neoplastic  potential,  characterised   by spindle  cell  proliferation  with  characteristic  fibroinflammatory  and  pseudosarcomatous  appearance.  A  subset  of  IMT  with  histologic  atypia  and/or  clinical  aggressiveness  is also  known. IMTs  occur  in  the  mesentery,  omentum,  retroperitoneum,  pelvis, and  abdominal  soft  tissues. However,  the  occurrence  of  IMT  in urinary  bladder  is  unusual. IMT  exhibits  morphologic  and  immunophenotypic  overlap with  malignant  spindle  cell  tumors  of  the  urinary  bladder  and  is diagnostically challenging. In  the  case  presented, ALK-1  and  SMA  immunostains helped  to  identify  IMT. Anaplastic  Lymphoma  Kinase  (ALK)  gene  translocation  or  ALK  gene  expression  can  further  confirm  IMT. Complete  surgical  excision  with  follow-up  is  the  treatment  of  choice  for  IMT. DOI: 10.21276/APALM.1129 

Author Biographies

Ronica Baruah, Ekopath Metropolis Lab Services Pvt. Ltd. Christian Basti, G.S.Road, Guwahati, Assam.
Pathologist
Abhijit Kalita, Ekopath Metropolis Lab Services Pvt. Ltd. Christian Basti, G.S.Road, Guwahati, Assam.
Pathologist
Phanindra Mohan Deka, Department of Urology, Dispur Hospitals Pvt. Ltd., Guwahati
Urologist

References

1. Etani T, Naiki T, Nagai T, Lida K, Ando R, Naiki-Ito A et al. Inflammatory Myofibroblastic tumor of urinary bladder; A case report. Case Rep Oncol 2016; 9(2) : 464-469
2. Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. Vol. 5. Lyon : IARC Press ; 2013 ; 83–84.
3. Coffin CM, Hornick JL, Flethcher CD. Inflammatory myofibroblastic tumor: Comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypicall and aggressive cases. Am J Sur Pathol 2007; 31(4): 509-520
4. Rao RN, Ranjan P, Singla N, Pandey R. Inflammatory myofibroblastic tumor of the urinary bladder diagnosed by anaplastic lymphoma kinase immunostaining. Urol Ann 2012; 4(2): 115-118
5. Dobrosz Z, Rys J, Palen P, Wlaszczuk P, Ciepiela M. Inflammatory myofibroblastic tumor of the bladder – an unexpected case co-existing with an ovarian teratoma. Diagnost Pathol 2014:9;138
6. Pettinano G, Manivel JL, De Rosa N, Dehner LP. IMT (plasma cell granuloma): Clinico-pathologic study of 20 cases with immunohistochemical and ultrastructural observations. Am J Clin Pathol 1990; 94: 538-546
7. Yagnik V, Chadha A, Chaudhari S, Patel K. Inflammatory myofibroblastic tumor of the urinary bladder. Urol Ann 2010; 2(2): 78-79
8. Mills SE. Editor. Sternberg’s Diagnostic Surgical Pathology. 5th ed.; Lippincott Williams & Wilkins; 2010
9. Zhao J, Ping H, Xing N. Post-operative spindle cell nodule of the bladder : a case report and review of literature. Oncol Lett. 2014; 7(5): 1507-1510
10. Toyonori T, Christina M, Jonathan E. ALK-1 Expression in Inflammatory Myofibroblastic Tumor of the Urinary bladder. Am J Sur Pathol 2004; 28(12): 1609-1614
11. Tanny SPT, Wang LL, Liddell HA, Longano A, Appu S, Shahbaz S. Inflammatory myofibroblastic tumor of the urinary bladder : a case report. Urol Case Rep 2016 ; 6: 58-59
Published
2017-03-28
Section
Case Report